The use of NovaSure for endometrial ablation results a variety of poor pregnancy outcomes, according to a study presented by Shannon Smith, MD, at the Global Congress of the American Association of Gynecologic Laparoscopists.
The use of NovaSure for endometrial ablation results a variety of poor pregnancy outcomes, according to a study presented by Shannon Smith, MD, at the Global Congress of the American Association of Gynecologic Laparoscopists.
In the study, “Pregnancy Outcomes following NovaSure Endometrial Ablation Procedure,” Smith said pregnancy after radiofrequency endometrial ablation is rare, and results in significant complications, morbidity and adverse outcomes for both the patient and fetus. The study aimed to determine whether contraceptive counseling was provided after ablation, and evaluate the outcomes of pregnancies that occurred following endometrial ablation using NovaSure.
The study included preliminary results for six of 20 patients who became pregnant following a NovaSure ablation procedure. Patents were from multiple centers around the United States.
A survey of physicians indicated that four pregnancies resulted in preterm birth between 27 and 36 weeks. One ended in spontaneous abortion in the first trimester; another was continuing into the third trimester without complications.
At conception, patients were between 26 and 29 years old; none reported using a reliable method of birth control. One patient received contraceptive counseling; three did not. One patient was unsure whether she’d been counseled to use contraception.
When pregnancy continued past the first trimester, a number of complications arose:
• Intrauterine growth restriction (IUGR) requiring cesarean hysterectomy,
• Preterm premature rupture of the membrane, placenta acretia, postpartum pyelonephritis with sepsis.
• Fetal distress/decelerations, terminal bradycardia
• IUGR, non-reassuring fetal heart tracing
Smith said, “These results emphasize the importance of physician counseling on the use of a reliable birth control method for patients undergoing endometrial ablation.”
Advancing obstetric and gynecologic surgery through robotic innovation
April 30th 2024Explore how robotic surgery revolutionizes obstetric and gynecologic procedures, offering enhanced precision, reduced complications, and improved patient outcomes, while also examining challenges and future prospects in the field.
Read More
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More